Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001834411-26-000004
Filing Date
2026-02-27
Accepted
2026-02-27 14:48:34
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772221711.html 4  
1 FORM 4 wk-form4_1772221711.xml 4 3874
  Complete submission text file 0001834411-26-000004.txt   5295
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ABCELLERA BIOLOGICS INC. 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address
Booth Andrew (Reporting) CIK: 0001834411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 26698237